Mary Gerritsen
49Patents
10h-index
47Co-inventors
71Inventor score
Filing activity: Feb 14, 2001 → Jul 31, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6635468B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 66 | Expired |
| US7390879B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Chemistry; Metallurgy | 36 | Expired |
| US7189563B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 32 | Expired |
| US7074592B2 | Secreted and transmembrane polypeptides nucleic acid encoding | Chemistry; Metallurgy | 25 | Expired |
| US6974689B1 | Nucleic acid encoding PRO211 polypeptides | Chemistry; Metallurgy | 24 | Expired |
| US7029874B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Physics | 21 | Expired |
| US9572811B2 | Treatment of dry eye | Human Necessities | 15 | Active |
| US7704498B2 | ErbB4 antagonists | Chemistry; Metallurgy | 15 | Active |
| US7189529B2 | PRO792 nucleic acids | Chemistry; Metallurgy | 12 | Expired |
| US7094567B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7332579B2 | Antibodies to human ErbB4 | Chemistry; Metallurgy | 9 | Expired |
| US7056736B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6858427B2 | Sphingosine kinases | Human Necessities | 5 | Expired |
| US7109305B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7196165B2 | PRO363 polypeptides | Chemistry; Metallurgy | 4 | Expired |
| US6723535B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6664376B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 3 | Expired |
| US8222271B2 | Formulations and methods for vascular permeability-related diseases or conditions | Human Necessities | 3 | Active |
| US7135334B2 | PRO20044 nucleic acids | Chemistry; Metallurgy | 3 | Expired |
| US7407660B2 | Methods and compositions for selective modulation of vascularization | Human Necessities | 2 | Expired |
| US7572447B2 | Methods and compositions for selective modulation of vascularization | Human Necessities | 2 | Active |
| US7018837B2 | Nucleic acids encoding secreted polypeptides that stimulate release of proteoglycans from cartilage | Chemistry; Metallurgy | 1 | Expired |
| US6936254B2 | Method of inducing fetal hemoglobin synthesis | Chemistry; Metallurgy | 1 | Expired |
| US7317092B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8486960B2 | Formulations and methods for vascular permeability-related diseases or conditions | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.